Company profile · Sponsor
Inhibitor
Inhibitor Therapeutics
- Pipeline
- 2
- Drugs
- 0
- Patents
- 5
Quick answer
Inhibitor (INTI) is a pharma company. headquartered in TAMPA, FL, USA. listed on NYSE. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 5 patents to this profile..
Company facts
Pipeline (2)
Search pipeline →Patents (5)
Search patents →-
US 11931402
Compositions for treating heart disease by inhibiting the action of mAKAP-β
granted -
US 11229679
Compositions for treating heart disease by inhibiting the action of mAKAPβ
granted -
US 10617737
Compositions for treating heart disease by inhibiting the action of mAKAP-β
granted -
US 9937228
Treatment of myocardial infarction by inhibiting the action of mAKAPβ
granted -
US 9132174
Treatment of heart disease by inhibition of the action of ribosomal S6 kinase 3 (RSK3)
granted
Frequently asked questions
What is Inhibitor?
Inhibitor (INTI) is a pharma company. headquartered in TAMPA, FL, USA. listed on NYSE. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 5 patents to this profile..
What pipeline programs does Inhibitor sponsor?
We track 2 ClinicalTrials.gov-linked programs for Inhibitor, including Small RNA sequencing and 1 more. Open each program for phase, modality, NCT IDs, and indication details.
Where does Inhibitor company data come from?
Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.